Global segment ranking · Healthtech › Clinical software

The world’s most valuable clinic management software companies

Practice-management SaaS for independent clinics, dental, allied health and veterinary practices: scheduling, billing, patient records and front-office automation. Ranked worldwide by AI-estimated valuation. The market sets the value; our AI estimates it.

Edition 0 (beta) · Published September 29, 2026 Twice a yearNext edition: January 1, 2027· Claude · multi-AI consensus in a future edition· Published method· Order never changed by a human

Key metrics for this segment: practices / practitioners served, revenue. Figures as published by each company or the press, dated, not recalculated. The AIs weigh them alongside funding history and comparables.

Not in this segment. Hospital and clinician-facing software (EHR, AI scribes, decision support), appointment booking marketplaces, telemedicine and mental health platforms each have their own segment. A company appears in one segment only. Method

The segment at a glance

11companies ranked

3companies on the radar

6countries in the ranking

4listed benchmarks

Sources: The Globe and Mail, Techcouver, Fierce Healthcare, MobiHealthNews, UKTN, SmartCompany, PR Newswire, Tech Startups, Romania Insider, Indian Startup News, Sina Finance, Investcorp, company announcements. Intention counters will be shown above a threshold of amount and number of Backers.

Rankings by region

Filter the ranking and the Radar. Ranks stay worldwide.

Global ranking · Clinic management

Top 11 Radar Challengers

First edition: no movements yet.

World · 11 ranked companies

#	Company	Last round · Key metrics	Estimated valuation (AI, order of magnitude)	Confidence	Invest
1	JaneCanada · North AmericaSources: 1 · 2Is this your company? Report an error	Secondary · USD 500M+ (secondary) · May 2025200,000+ practitioners in 50,000 clinics (CA, US, UK) · Revenue close to US$100M · 2025	Last known equity round: Secondary · USD 500M+ (secondary) · May 2025 (led by TCV, with JMI Equity and Tidemark) Published valuation: about USD 1.8bn (May 2025) Confidence index: HighMethod	Solid sources	Declare an intent
2	NexHealthUnited States · North AmericaSources: 1 · 2Is this your company? Report an error	Series C · USD 125M · Apr 202268M patient records managed · Revenue: n/d · Apr 2022	Last known equity round: Series C · USD 125M · Apr 2022 (led by Buckley Ventures) Published valuation: USD 1bn (Apr 2022) Confidence index: MediumMethod	Partial sources	Declare an intent
3	LinkedcareChina · Asia-PacificSources: 1 · 2Is this your company? Report an error	Series E · hundreds of millions of RMB · Jan 202550,000+ dental and aesthetic clinics · Revenue: n/d · Jan 2025	Last known equity round: Series E · hundreds of millions of RMB · Jan 2025 (not disclosed) No confirmed published valuation Confidence index: LowMethod	Weak sources	Declare an intent
4	Elation HealthUnited States · North AmericaSources: 1Is this your company? Report an error	Series D · USD 50M · Jul 202224,000+ clinicians, 12.8M patients · Revenue: n/d · Jul 2022	Last known equity round: Series D · USD 50M · Jul 2022 (co-led by Generation Investment Management and Ascension Ventures) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
5	SembleUnited Kingdom · EuropeSources: 1 · 2Is this your company? Report an error	Series C · GBP 30M · Jun 20261,700 customers, 16,000 daily professionals, 10M+ patients · Revenue: n/d · Jun 2026	Last known equity round: Series C · GBP 30M · Jun 2026 (led by Revaia, with Partech, Mercia Ventures, Octopus Ventures) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
6	HealthieUnited States · North AmericaSources: 1Is this your company? Report an error	Series B · USD 23M · Oct 202425,000+ clinicians, 10M+ patients · Revenue: n/d · Oct 2024	Last known equity round: Series B · USD 23M · Oct 2024 (led by TCV) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
7	SploseAustralia · Asia-PacificSources: 1 · 2Is this your company? Report an error	Series A · AUD 46M · Feb 202620,000+ allied health practitioners (AU, NZ, UK) · Revenue: n/d · Feb 2026	Last known equity round: Series A · AUD 46M · Feb 2026 (led by Spectrum Equity, with Athletic Ventures) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
8	ArchyUnited States · North AmericaSources: 1 · 2Is this your company? Report an error	Series B · USD 20M · Oct 2025Dental practices in 45 states; $100M+ annual payments processed · Revenue: n/d · Oct 2025	Last known equity round: Series B · USD 20M · Oct 2025 (led by TCV, with Bessemer, CRV, Entrée Capital) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
9	DigitailUnited States · North AmericaSources: 1 · 2Is this your company? Report an error	Series B · USD 23M · Nov 202510,000+ veterinarians, 3M pet parents · Revenue: n/d · Nov 2025	Last known equity round: Series B · USD 23M · Nov 2025 (led by Five Elms Capital, with Atomico, Partech) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
10	HealthPlixIndia · Asia-PacificSources: 1Is this your company? Report an error	Series C · USD 22M · Mar 202310,000+ doctors · Revenue: n/d · Mar 2023	Last known equity round: Series C · USD 22M · Mar 2023 (led by Avataar Venture Partners and SIG) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent
11	SPRYUnited States · North AmericaSources: 1Is this your company? Report an error	Series B · USD 15M · Oct 2024105+ PT clinics in 30 US states · Revenue: n/d · Oct 2024	Last known equity round: Series B · USD 15M · Oct 2024 (led by Flourish Ventures, with Eight Roads, F-Prime) No confirmed published valuation Confidence index: MediumMethod	Partial sources	Declare an intent

Ranking in descending order of AI-estimated valuation, based on public information, following a published method, with no human intervention on the order. Valuation ranges are indicative editorial estimates: neither a financial valuation, nor an offer, nor investment advice. Only the market sets a company’s value, through a funding round or a sale. Edition 0: produced by Claude (Anthropic); a consensus of several AI models will apply in a future edition. Eligibility: at least $1M raised including one equity round, non-listed company, main activity in this segment (practice-management software for independent clinics, dental, allied health and veterinary practices). Country shown is the country of main operations. Request a correction

Get every new edition

New entries, exits and movements, twice a year.

One e-mail per edition. One-click unsubscribe. No data passed on to third parties.

How to read this ranking

Rank

Companies are ranked by AI-estimated valuation, highest first. The market sets the value; our AI estimates it.

Range

An order of magnitude, never a figure.

Hundreds of k$
Millions $
Tens of M$
Hundreds of M$
Unicorn
Decacorn

Confidence

High: recent published valuation or round (under 24 months).
Medium: older data.
Low: single or unconfirmed source.

Full method →

Invest in clinic management, together

Uback aggregates investment intentions from business angels, family offices, corporates and sector specialists worldwide. Every ranked company already has professional investors on its cap table, who have negotiated a shareholders’ agreement: you don’t start from a blank page.

Strength in numbers

Alone, a small ticket opens no doors. Together, Backers carry weight.

Declare an intention

On a company or a sector, with a ticket range. Paid, to show you are serious; transferable as long as it has not been converted.

Critical mass is reached

When the number of Backers and the total of their intentions cross a threshold, the licensed partner contacts the company and presents this demand.

The licensed partner structures

If the company’s expectations and the Backers’ converge, the partner builds a transaction and presents it directly to the Backers concerned.

Closing

Capital raise or sale of existing shares: small tickets are pooled in a common vehicle set up by the licensed partner. Each Backer decides whether to take part.

Uback does not advise, does not negotiate, collects nothing. Each transaction is run by the licensed partner of the company’s country, under the law that governs its shares.

Get notified when intentions open What happens after my declaration? Intention declarations open once the licensed partner signs · price per ticket band · valid 12 months · transferable credit

Challengers

A registered company raising funds that is not in the ranking will be able, for a fee, to appear in a separate list labelled “Challengers”, for a set period, with a memo available to verified Backers. The listing has no effect on the ranking. Not open yet.

Sponsored space · no Challenger listed yet

Radar · known eligible companies, not ranked

Sorted by date of last round, with no judgement and no AI call.

Klinik Pintar · Indonesia · Asia-PacificDec 2023 · USD 5M
Carepatron · New Zealand · Asia-PacificAug 2023 · USD 4M
Eka Care · India · Asia-PacificJun 2022 · USD 15M

Listed benchmarks

Not ranked: no intention is possible on a listed company.

Weave Communications · United StatesNYSE · WEAV
Phreesia · United StatesNYSE · PHR
Nordhealth · FinlandEuronext Growth Oslo · NORDH
Medley · JapanTSE · 4480

Sources and method for this segment

Calendar. Global segment rankings are published twice a year. Next edition: January 1, 2027.

Eligibility. At least $1M raised including one equity round, non-listed company, main activity in this segment (practice-management software for independent clinics, dental, allied health and veterinary practices). A company appears in one segment only.

Sources. The Globe and Mail, Techcouver, Fierce Healthcare, MobiHealthNews, UKTN, SmartCompany, PR Newswire, Tech Startups, Romania Insider, Indian Startup News, Sina Finance, Investcorp, company announcements.

Method and rules, common to all rankings →